We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: news

Innovative Prosthetic Capsular Bag Enables Secure Scleral Fixation of Intraocular Lenses Without Capsular Support

MedXY Editorial Team•Aug 23, 2026•news
Intraocular Lensophthalmologyscleral fixationcapsular supportprosthetic capsular bag

Highlight

  • Introduction of a prosthetic capsular bag (PCB) as a sutureless scleral fixation platform for secondary intraocular lenses (IOL) in eyes without capsular support.
  • First-in-human prospective study shows favorable safety profile with only one device-related serious adverse event.
  • Over 90% of patients maintain or improve best-corrected visual acuity, with significant gains in uncorrected visual acuity.
  • PCB demonstrated reliable refractive accuracy with low variability in spherical equivalent outcomes.

Study Background

Patients with insufficient capsular or zonular integrity pose a significant clinical challenge when secondary intraocular lens (IOL) implantation is required. Traditional fixation options, including anterior chamber IOLs, iris-fixated IOLs, or scleral-sutured IOLs, often present technical complexity and a high incidence of complications such as IOL dislocation, conjunctival erosion, and inflammation. The absence of a stable capsular bag, which normally supports the IOL, leaves surgeons reliant on alternative fixation methods that may compromise anatomical and refractive outcomes. The prosthetic capsular bag (PCB) was developed to address this unmet clinical need by providing a secure, sutureless scleral fixation platform for posterior chamber IOLs in eyes lacking native capsular or zonular support.

Study Design

This was a multicenter, prospective, open-label, single-arm exploratory first-in-human study conducted at three retina centers in Sydney, Australia. Fifteen patients with inadequate capsular or zonular integrity necessitating secondary IOL implantation were enrolled. Indications included removal of dislocated crystalline lenses and previously implanted IOLs as clinically indicated.

Surgical intervention entailed pars plana vitrectomy followed by insertion of the PCB through a standard IOL injector. The PCB could be inserted with or without a preloaded IOL. The PCB featured three fixation arms that were secured transsclerally without the need for sutures or scleral pockets, representing a novel sutureless fixation technique designed to minimize tissue trauma and risk of conjunctival erosion.

The primary endpoint was the incidence and characterization of adverse events related to the PCB device up to 12 months postoperatively. Secondary assessments included visual acuity outcomes, refractive stability, and device integrity.

Key Findings

All 15 patients completed the 12-month follow-up period. The safety profile of the PCB was favorable with no cases of conjunctival erosion over the fixation arms or IOL dislocation from the prosthetic bag noted. One serious device-related adverse event was reported in a patient with Marfan’s syndrome, where reinternalization of a single footplate occurred, necessitating secondary surgery to refixate the footplate. This highlights the importance of patient selection and monitoring in connective tissue disorders.

Visual acuity outcomes were robust. Ninety-three percent of patients maintained best-corrected visual acuity (BCVA) within one line of their preoperative baseline, indicating stability of vision post-implantation. Notably, uncorrected visual acuity (UCVA) improved on average by 12 lines, with 71% of patients achieving UCVA within two lines of their baseline BCVA. This suggests the PCB not only maintained but often enhanced visual function.

Refractive outcomes demonstrated excellent predictability, with a mean spherical equivalent of +0.12 diopters (standard deviation of 0.39 D), signifying minimal refractive variability and high accuracy of lens positioning within the prosthetic bag platform.

Expert Commentary

The development of a prosthetic capsular bag represents a significant advancement in secondary IOL implantation techniques, particularly for eyes lacking capsular support. Conventional scleral fixation techniques frequently rely on sutures or complex scleral flap construction, which may predispose to suture-related erosion, late IOL dislocation, and longer surgical time. By obviating the need for sutures and scleral pockets, the PCB streamlines the surgical procedure while potentially reducing the risk of complications.

The single serious adverse event in a patient with Marfan’s syndrome underscores that connective tissue disorders may pose unique challenges even with innovative devices. Further studies with larger sample sizes and longer follow-up are essential to verify long-term device safety and effectiveness. Additionally, comparative trials against established fixation methods would clarify relative benefits and limitations.

Mechanistically, the PCB mimics the anatomical support function of the natural capsular bag, providing centration and stability to the IOL and maintaining appropriate lens position within the posterior chamber—key determinants of optimal refractive outcomes. This aligns with understanding that IOL decentration or tilt can significantly impact visual quality and refractive predictability.

Conclusion

This initial human study suggests that the prosthetic capsular bag is a viable and innovative platform for secure scleral fixation of posterior chamber IOLs in eyes without residual capsular or zonular support. It offers a sutureless, stable fixation approach with encouraging visual and refractive outcomes and a low complication rate. If confirmed in subsequent larger-scale studies, the PCB may become a preferred solution for complex secondary IOL implantations, improving patient outcomes in this challenging clinical scenario.

Funding and Registration

The study disclosed proprietary or commercial interests in the footnotes and disclosures sections. Specific funding sources were not detailed in the abstract. Additional clinical studies are planned to further evaluate this technology.

References

  • Brodie FL, Naseri A, Ho IV, et al. Clinical Outcomes of a Prosthetic Capsular Bag for Scleral Fixation of an Intraocular Lens in Eyes without Capsular Support. Ophthalmology. 2026;133(8):965-970. PMID: 42036076.
  • Gabor SG, Roman L. Transscleral sutured posterior chamber intraocular lens implantation in the absence of capsule support. J Cataract Refract Surg. 1997 Feb;23(2):166-72.
  • Sheng T, Qian T, Peng T, Liu Y, Liang S. Outcomes of scleral fixation of intraocular lenses. Eye Sci. 2017 Mar;32(1):45-50.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Distinct Molecular and Clinical Profiles of USH2A-Associated Retinitis Pigmentosa in Korean Patients: Implications for Targeted TherapyThis study elucidates the unique East Asian-specific genetic variants and clinical progression of USH2A-associated retinitis pigmentosa in Koreans, highlighting the potential for exon 13-targeted treatments.Sep 19, 2026Evolving Microbial Landscape and Clinical Profiles in Postcataract Endophthalmitis: Insights from a 23-Year Retrospective Cohort StudyThis study reveals significant shifts in the bacterial spectrum, antimicrobial resistance, and clinical presentation of acute postcataract endophthalmitis over 23 years, underscoring the need for updated surveillance and tailored treatmentSep 13, 2026Widening the Spectrum of Disease Expression due to Heterozygous Variants in EFEMP1A case series delineating a novel EFEMP1 variant, p.Arg140Trp, associated with late-onset peripheral retinal degeneration distinct from classic DHRD/ML, highlighting rod dysfunction precedes structural changes.Sep 13, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
AI Writing Vocabulary in Ophthalmology: Faster Non-Native Adoption, Unchanged Outcomes
This study examines the increased use of AI-associated writing vocabulary in ophthalmology articles, revealing faster adoption by non-native English authors without changes in publication frequency or journal quality.
Aug 25, 2026
Ultra-Long-Distance Robotic-Assisted Subretinal Injection for Submacular Hemorrhage: A Case ReportThis report describes the successful ultra-long-distance robotic-assisted subretinal injection of recombinant tissue plasminogen activator for submacular hemorrhage, demonstrating procedural feasibility and safety across 4000 km.Aug 23, 2026
Understanding Contemporary Intraocular Lens-Associated Uveitis-Glaucoma-Hyphema (UGH) Syndrome: Clinical Insights and ManagementThis article reviews clinical characteristics, onset timing, management, and outcomes of intraocular lens-associated UGH syndrome, highlighting challenges with late-onset disease and persistent ocular hypertension despite treatment.Aug 23, 2026